IVD China last week: Roche, Siemens, Wondfo, MGI, Vazyme and Oriental Gene

Roche Invests Over 2 Billion CNY to Establish New Production Base in Pudong, Shanghai

The groundbreaking ceremony for Roche China's new biopharmaceutical production base was held at the Zhangjiang Science Hall. With a total investment of 2.04 billion CNY, the first phase of the project will focus on localized production of treatments for retinal diseases, aiming to accelerate access to high-quality medicines for Chinese patients.

Siemens Launches Xcelerator Industrial Ecosystem Western Center in Chengdu

Siemens Xcelerator Industrial Ecosystem Western Center commenced operations at the AI Digital Innovation Park in Jinniu District, Chengdu. As Siemens' first industrial ecosystem hub in western China, it was jointly established by the People's Government of Jinniu District, Siemens Digital Technology (Shenzhen) Co., Ltd., and JiaDu Group.

The center will leverage the open digital business platform Siemens Xcelerator to drive deep integration of advanced manufacturing and cutting-edge digital technologies. Through the Siemens Xcelerator ecosystem partner network, it will expand industrial collaboration, empowering local enterprises to accelerate their digital, intelligent, and low-carbon transformation.

Wondfo Biotech Expands Global Footprint with New Subsidiaries in Russia and the Philippines

Recently, Wondfo Biotech's subsidiaries in Russia and the Philippines were successively established and officially commenced operations. In active response to the Belt and Road Initiative and committed to high-quality global expansion, Wondfo continues to advance its internationalization strategy and deepen its worldwide presence by strengthening localized operations in key markets.

Moving forward, Wondfo Biotech will collaborate with partners to further cultivate overseas markets, making biotechnology accessible and beneficial to all.

MGI Subsidiary Complete Genomics Announces Collaboration with U.S. Velsera 

Recently, at the annual meeting of the American Association for Cancer Research (AACR) in Chicago, U.S.-based medical technology company Velsera announced a collaboration with MGI’s subsidiary, Complete Genomics.

Vazyme Biotech and Oriental Gene Partner to Advance Precision Medical Diagnostics

On May 5, Vazyme Biotech and Oriental Gene officially signed a strategic cooperation agreement. At this critical juncture of advancing intelligence and precision in life sciences and medical diagnostics, the collaboration will focus on cutting-edge fields such as key raw material development, Alzheimer's disease diagnosis, and molecular microfluidics. Together, the two companies aim to drive long-term progress in life sciences and medical diagnostics, leveraging technological innovation to transform the industry and contribute China's expertise to global healthcare diagnostics.